Global Brucellosis Vaccines Market Research Report 2020

Global Brucellosis Vaccines Market Research Report 2020

Table of Contents
1 Brucellosis Vaccines Market Overview
1.1 Product Overview and Scope of Brucellosis Vaccines
1.2 Brucellosis Vaccines Segment by Type
1.2.1 Global Brucellosis Vaccines Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 S19 Vaccine
1.2.3 RB51 Vaccine Strain
1.2.4 Other
1.3 Brucellosis Vaccines Segment by Application
1.3.1 Brucellosis Vaccines Sales Comparison by Application: 2020 VS 2026
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Other
1.4 Global Brucellosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Brucellosis Vaccines Revenue 2015-2026
1.4.2 Global Brucellosis Vaccines Sales 2015-2026
1.4.3 Brucellosis Vaccines Market Size by Region: 2020 Versus 2026
2 Global Brucellosis Vaccines Market Competition by Manufacturers
2.1 Global Brucellosis Vaccines Sales Market Share by Manufacturers (2015-2020)
2.2 Global Brucellosis Vaccines Revenue Share by Manufacturers (2015-2020)
2.3 Global Brucellosis Vaccines Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Brucellosis Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Brucellosis Vaccines Market Competitive Situation and Trends
2.5.1 Brucellosis Vaccines Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Brucellosis Vaccines Players (Opinion Leaders)
3 Brucellosis Vaccines Retrospective Market Scenario by Region
3.1 Global Brucellosis Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Brucellosis Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Brucellosis Vaccines Market Facts & Figures by Country
3.3.1 North America Brucellosis Vaccines Sales by Country
3.3.2 North America Brucellosis Vaccines Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Brucellosis Vaccines Market Facts & Figures by Country
3.4.1 Europe Brucellosis Vaccines Sales by Country
3.4.2 Europe Brucellosis Vaccines Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Brucellosis Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Brucellosis Vaccines Sales by Region
3.5.2 Asia Pacific Brucellosis Vaccines Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Brucellosis Vaccines Market Facts & Figures by Country
3.6.1 Latin America Brucellosis Vaccines Sales by Country
3.6.2 Latin America Brucellosis Vaccines Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Brucellosis Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Brucellosis Vaccines Sales by Country
3.7.2 Middle East and Africa Brucellosis Vaccines Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Brucellosis Vaccines Historic Market Analysis by Type
4.1 Global Brucellosis Vaccines Sales Market Share by Type (2015-2020)
4.2 Global Brucellosis Vaccines Revenue Market Share by Type (2015-2020)
4.3 Global Brucellosis Vaccines Price Market Share by Type (2015-2020)
4.4 Global Brucellosis Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Brucellosis Vaccines Historic Market Analysis by Application
5.1 Global Brucellosis Vaccines Sales Market Share by Application (2015-2020)
5.2 Global Brucellosis Vaccines Revenue Market Share by Application (2015-2020)
5.3 Global Brucellosis Vaccines Price by Application (2015-2020)
6 Company Profiles and Key Figures in Brucellosis Vaccines Business
6.1 Jinyu
6.1.1 Corporation Information
6.1.2 Jinyu Description, Business Overview and Total Revenue
6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Jinyu Products Offered
6.1.5 Jinyu Recent Development
6.2 Colorado Serum
6.2.1 Colorado Serum Brucellosis Vaccines Production Sites and Area Served
6.2.2 Colorado Serum Description, Business Overview and Total Revenue
6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Colorado Serum Products Offered
6.2.5 Colorado Serum Recent Development
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Brucellosis Vaccines Production Sites and Area Served
6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Boehringer Ingelheim Products Offered
6.3.5 Boehringer Ingelheim Recent Development
6.4 Biogenesis-Bago
6.4.1 Biogenesis-Bago Brucellosis Vaccines Production Sites and Area Served
6.4.2 Biogenesis-Bago Description, Business Overview and Total Revenue
6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Biogenesis-Bago Products Offered
6.4.5 Biogenesis-Bago Recent Development
6.5 Vetal Company
6.5.1 Vetal Company Brucellosis Vaccines Production Sites and Area Served
6.5.2 Vetal Company Description, Business Overview and Total Revenue
6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Vetal Company Products Offered
6.5.5 Vetal Company Recent Development
6.6 CZ Veterinaria
6.6.1 CZ Veterinaria Brucellosis Vaccines Production Sites and Area Served
6.6.2 CZ Veterinaria Description, Business Overview and Total Revenue
6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.6.4 CZ Veterinaria Products Offered
6.6.5 CZ Veterinaria Recent Development
6.7 SYVA Laboratorios
6.6.1 SYVA Laboratorios Brucellosis Vaccines Production Sites and Area Served
6.6.2 SYVA Laboratorios Description, Business Overview and Total Revenue
6.6.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.4.4 SYVA Laboratorios Products Offered
6.7.5 SYVA Laboratorios Recent Development
6.8 Indian Immunologicals
6.8.1 Indian Immunologicals Brucellosis Vaccines Production Sites and Area Served
6.8.2 Indian Immunologicals Description, Business Overview and Total Revenue
6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Indian Immunologicals Products Offered
6.8.5 Indian Immunologicals Recent Development
6.9 Qilu
6.9.1 Qilu Brucellosis Vaccines Production Sites and Area Served
6.9.2 Qilu Description, Business Overview and Total Revenue
6.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Qilu Products Offered
6.9.5 Qilu Recent Development
6.10 Tecnovax
6.10.1 Tecnovax Brucellosis Vaccines Production Sites and Area Served
6.10.2 Tecnovax Description, Business Overview and Total Revenue
6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Tecnovax Products Offered
6.10.5 Tecnovax Recent Development
6.11 Hester Biosciences
6.11.1 Hester Biosciences Brucellosis Vaccines Production Sites and Area Served
6.11.2 Hester Biosciences Brucellosis Vaccines Description, Business Overview and Total Revenue
6.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Hester Biosciences Products Offered
6.11.5 Hester Biosciences Recent Development
6.12 Zoetis
6.12.1 Zoetis Brucellosis Vaccines Production Sites and Area Served
6.12.2 Zoetis Brucellosis Vaccines Description, Business Overview and Total Revenue
6.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Zoetis Products Offered
6.12.5 Zoetis Recent Development
6.13 Onderstepoort Biological
6.13.1 Onderstepoort Biological Brucellosis Vaccines Production Sites and Area Served
6.13.2 Onderstepoort Biological Brucellosis Vaccines Description, Business Overview and Total Revenue
6.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Onderstepoort Biological Products Offered
6.13.5 Onderstepoort Biological Recent Development
6.14 Instituto Rosenbusch
6.14.1 Instituto Rosenbusch Brucellosis Vaccines Production Sites and Area Served
6.14.2 Instituto Rosenbusch Brucellosis Vaccines Description, Business Overview and Total Revenue
6.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Instituto Rosenbusch Products Offered
6.14.5 Instituto Rosenbusch Recent Development
6.15 Ceva Sante Animale
6.15.1 Ceva Sante Animale Brucellosis Vaccines Production Sites and Area Served
6.15.2 Ceva Sante Animale Brucellosis Vaccines Description, Business Overview and Total Revenue
6.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Ceva Sante Animale Products Offered
6.15.5 Ceva Sante Animale Recent Development
6.16 Calier & Biologicos Laverlam
6.16.1 Calier & Biologicos Laverlam Brucellosis Vaccines Production Sites and Area Served
6.16.2 Calier & Biologicos Laverlam Brucellosis Vaccines Description, Business Overview and Total Revenue
6.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Calier & Biologicos Laverlam Products Offered
6.16.5 Calier & Biologicos Laverlam Recent Development
6.17 Biovet
6.17.1 Biovet Brucellosis Vaccines Production Sites and Area Served
6.17.2 Biovet Brucellosis Vaccines Description, Business Overview and Total Revenue
6.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Biovet Products Offered
6.17.5 Biovet Recent Development
7 Brucellosis Vaccines Manufacturing Cost Analysis
7.1 Brucellosis Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Brucellosis Vaccines
7.4 Brucellosis Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Brucellosis Vaccines Distributors List
8.3 Brucellosis Vaccines Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Brucellosis Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Brucellosis Vaccines by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Brucellosis Vaccines by Type (2021-2026)
10.2 Brucellosis Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Brucellosis Vaccines by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Brucellosis Vaccines by Application (2021-2026)
10.3 Brucellosis Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Brucellosis Vaccines by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Brucellosis Vaccines by Region (2021-2026)
10.4 North America Brucellosis Vaccines Estimates and Projections (2021-2026)
10.5 Europe Brucellosis Vaccines Estimates and Projections (2021-2026)
10.6 Asia Pacific Brucellosis Vaccines Estimates and Projections (2021-2026)
10.7 Latin America Brucellosis Vaccines Estimates and Projections (2021-2026)
10.8 Middle East and Africa Brucellosis Vaccines Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Brucellosis Vaccines Sales (M Doses) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Brucellosis Vaccines Sales (M Doses) Comparison by Application: 2020 VS 2026
Table 3. Global Brucellosis Vaccines Market Size by Type (M Doses) (US$ Million) (2020 VS 2026)
Table 4. Global Key Brucellosis Vaccines Manufacturers Covered in This Study
Table 5. Global Brucellosis Vaccines Sales (M Doses) by Manufacturers (2015-2020)
Table 6. Global Brucellosis Vaccines Sales Share by Manufacturers (2015-2020)
Table 7. Global Brucellosis Vaccines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Brucellosis Vaccines Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Brucellosis Vaccines Sales Sites and Area Served
Table 11. Manufacturers Brucellosis Vaccines Product Types
Table 12. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Brucellosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Brucellosis Vaccines Players
Table 16. Global Brucellosis Vaccines Sales (M Doses) by Region (2015-2020)
Table 17. Global Brucellosis Vaccines Sales Market Share by Region (2015-2020)
Table 18. Global Brucellosis Vaccines Revenue (Million US$) by Region (2015-2020)
Table 19. Global Brucellosis Vaccines Revenue Market Share by Region (2015-2020)
Table 20. North America Brucellosis Vaccines Sales by Country (2015-2020) (M Doses)
Table 21. North America Brucellosis Vaccines Sales Market Share by Country (2015-2020)
Table 22. North America Brucellosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Brucellosis Vaccines Revenue Market Share by Country (2015-2020)
Table 24. Europe Brucellosis Vaccines Sales by Country (2015-2020) (M Doses)
Table 25. Europe Brucellosis Vaccines Sales Market Share by Country (2015-2020)
Table 26. Europe Brucellosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Brucellosis Vaccines Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Brucellosis Vaccines Sales by Region (2015-2020) (M Doses)
Table 29. Asia Pacific Brucellosis Vaccines Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Brucellosis Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Brucellosis Vaccines Revenue Market Share by Region (2015-2020)
Table 32. Latin America Brucellosis Vaccines Sales by Country (2015-2020) (M Doses)
Table 33. Latin America Brucellosis Vaccines Sales Market Share by Country (2015-2020)
Table 34. Latin America Brucellosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Brucellosis Vaccines Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Brucellosis Vaccines Sales by Country (2015-2020) (M Doses)
Table 37. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Brucellosis Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2015-2020)
Table 40. Global Brucellosis Vaccines Sales (M Doses) by Type (2015-2020)
Table 41. Global Brucellosis Vaccines Sales Share by Type (2015-2020)
Table 42. Global Brucellosis Vaccines Revenue (Million US$) by Type (2015-2020)
Table 43. Global Brucellosis Vaccines Revenue Share by Type (2015-2020)
Table 44. Global Brucellosis Vaccines Price (USD/K Doses) by Type (2015-2020)
Table 45. Global Brucellosis Vaccines Sales (M Doses) by Application (2015-2020)
Table 46. Global Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Table 47. Global Brucellosis Vaccines Sales Growth Rate by Application (2015-2020)
Table 48. Jinyu Brucellosis Vaccines Corporation Information
Table 49. Jinyu Description and Business Overview
Table 50. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 51. Jinyu Main Product
Table 52. Jinyu Recent Development
Table 53. Colorado Serum Brucellosis Vaccines Corporation Information
Table 54. Colorado Serum Corporation Information
Table 55. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 56. Colorado Serum Main Product
Table 57. Colorado Serum Recent Development
Table 58. Boehringer Ingelheim Brucellosis Vaccines Corporation Information
Table 59. Boehringer Ingelheim Corporation Information
Table 60. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 61. Boehringer Ingelheim Main Product
Table 62. Boehringer Ingelheim Recent Development
Table 63. Biogenesis-Bago Brucellosis Vaccines Corporation Information
Table 64. Biogenesis-Bago Corporation Information
Table 65. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 66. Biogenesis-Bago Main Product
Table 67. Biogenesis-Bago Recent Development
Table 68. Vetal Company Brucellosis Vaccines Corporation Information
Table 69. Vetal Company Corporation Information
Table 70. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 71. Vetal Company Main Product
Table 72. Vetal Company Recent Development
Table 73. CZ Veterinaria Brucellosis Vaccines Corporation Information
Table 74. CZ Veterinaria Corporation Information
Table 75. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 76. CZ Veterinaria Main Product
Table 77. CZ Veterinaria Recent Development
Table 78. SYVA Laboratorios Brucellosis Vaccines Corporation Information
Table 79. SYVA Laboratorios Corporation Information
Table 80. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 81. SYVA Laboratorios Main Product
Table 82. SYVA Laboratorios Recent Development
Table 83. Indian Immunologicals Brucellosis Vaccines Corporation Information
Table 84. Indian Immunologicals Corporation Information
Table 85. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 86. Indian Immunologicals Main Product
Table 87. Indian Immunologicals Recent Development
Table 88. Qilu Brucellosis Vaccines Corporation Information
Table 89. Qilu Corporation Information
Table 90. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 91. Qilu Main Product
Table 92. Qilu Recent Development
Table 93. Tecnovax Brucellosis Vaccines Corporation Information
Table 94. Tecnovax Corporation Information
Table 95. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 96. Tecnovax Main Product
Table 97. Tecnovax Recent Development
Table 98. Hester Biosciences Brucellosis Vaccines Corporation Information
Table 99. Hester Biosciences Corporation Information
Table 100. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 101. Hester Biosciences Main Product
Table 102. Hester Biosciences Recent Development
Table 103. Zoetis Brucellosis Vaccines Corporation Information
Table 104. Zoetis Corporation Information
Table 105. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 106. Zoetis Main Product
Table 107. Zoetis Recent Development
Table 108. Onderstepoort Biological Brucellosis Vaccines Corporation Information
Table 109. Onderstepoort Biological Corporation Information
Table 110. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 111. Onderstepoort Biological Main Product
Table 112. Onderstepoort Biological Recent Development
Table 113. Instituto Rosenbusch Brucellosis Vaccines Corporation Information
Table 114. Instituto Rosenbusch Corporation Information
Table 115. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 116. Instituto Rosenbusch Main Product
Table 117. Instituto Rosenbusch Recent Development
Table 118. Ceva Sante Animale Brucellosis Vaccines Corporation Information
Table 119. Ceva Sante Animale Corporation Information
Table 120. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 121. Ceva Sante Animale Main Product
Table 122. Ceva Sante Animale Recent Development
Table 123. Calier & Biologicos Laverlam Brucellosis Vaccines Corporation Information
Table 124. Calier & Biologicos Laverlam Corporation Information
Table 125. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 126. Calier & Biologicos Laverlam Main Product
Table 127. Calier & Biologicos Laverlam Recent Development
Table 128. Biovet Brucellosis Vaccines Corporation Information
Table 129. Biovet Corporation Information
Table 130. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2015-2020)
Table 131. Biovet Main Product
Table 132. Biovet Recent Development
Table 133. Sales Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. Brucellosis Vaccines Distributors List
Table 136. Brucellosis Vaccines Customers List
Table 137. Market Key Trends
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Global Brucellosis Vaccines Sales (M Doses) Forecast by Type (2021-2026)
Table 141. Global Brucellosis Vaccines Sales Market Share Forecast by Type (2021-2026)
Table 142. Global Brucellosis Vaccines Revenue (Million US$) Forecast by Type (2021-2026)
Table 143. Global Brucellosis Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 144. Global Brucellosis Vaccines Sales (M Doses) Forecast by Application (2021-2026)
Table 145. Global Brucellosis Vaccines Revenue (Million US$) Forecast by Application (2021-2026)
Table 146. Global Brucellosis Vaccines Sales (M Doses) Forecast by Region (2021-2026)
Table 147. Global Brucellosis Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 148. Global Brucellosis Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Global Brucellosis Vaccines Revenue Market Share Forecast by Region (2021-2026)
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Brucellosis Vaccines
Figure 2. Global Brucellosis Vaccines Sales Market Share by Type: 2020 VS 2026
Figure 3. S19 Vaccine Product Picture
Figure 4. RB51 Vaccine Strain Product Picture
Figure 5. Other Product Picture
Figure 6. Global Brucellosis Vaccines Consumption Market Share by Application: 2020 VS 2026
Figure 7. Cattle
Figure 8. Sheep
Figure 9. Other
Figure 10. Global Brucellosis Vaccines Market Size 2015-2026 (US$ Million)
Figure 11. Global Brucellosis Vaccines Sales Capacity (M Doses) (2015-2026)
Figure 12. Global Brucellosis Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Brucellosis Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Brucellosis Vaccines Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Brucellosis Vaccines Revenue in 2019
Figure 16. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Brucellosis Vaccines Sales Market Share by Region (2015-2020)
Figure 18. Global Brucellosis Vaccines Sales Market Share by Region in 2019
Figure 19. Global Brucellosis Vaccines Revenue Market Share by Region (2015-2020)
Figure 20. Global Brucellosis Vaccines Revenue Market Share by Region in 2019
Figure 21. North America Brucellosis Vaccines Sales Market Share by Country in 2019
Figure 22. North America Brucellosis Vaccines Revenue Market Share by Country in 2019
Figure 23. U.S. Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 24. U.S. Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 26. Canada Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Brucellosis Vaccines Sales Market Share by Country in 2019
Figure 28. Europe Brucellosis Vaccines Revenue Market Share by Country in 2019
Figure 29. Germany Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 30. Germany Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 32. France Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 34. U.K. Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 36. Italy Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 38. Russia Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Brucellosis Vaccines Sales Market Share by Region in 2019
Figure 40. Asia Pacific Brucellosis Vaccines Revenue Market Share by Region in 2019
Figure 41. China Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 42. China Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 44. Japan Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 46. South Korea Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 48. India Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 50. Australia Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 52. Taiwan Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 54. Indonesia Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 56. Thailand Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 58. Malaysia Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 60. Philippines Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 62. Vietnam Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Brucellosis Vaccines Sales Market Share by Country in 2019
Figure 64. Latin America Brucellosis Vaccines Revenue Market Share by Country in 2019
Figure 65. Mexico Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 66. Mexico Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 68. Brazil Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 70. Argentina Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country in 2019
Figure 73. Turkey Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 74. Turkey Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 76. Saudi Arabia Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Brucellosis Vaccines Sales Growth Rate (2015-2020) (M Doses)
Figure 78. U.A.E Brucellosis Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Brucellosis Vaccines by Type (2015-2020)
Figure 80. Sales Market Share of Brucellosis Vaccines by Type in 2019
Figure 81. Revenue Share of Brucellosis Vaccines by Type (2015-2020)
Figure 82. Revenue Market Share of Brucellosis Vaccines by Type in 2019
Figure 83. Global Brucellosis Vaccines Sales Growth by Type (2015-2020) (M Doses)
Figure 84. Global Brucellosis Vaccines Sales Market Share by Application (2015-2020)
Figure 85. Global Brucellosis Vaccines Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Brucellosis Vaccines by Application (2015-2020)
Figure 87. Global Revenue Share of Brucellosis Vaccines by Application in 2020
Figure 88. Jinyu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Biogenesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Vetal Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. CZ Veterinaria Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. SYVA Laboratorios Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Qilu Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Tecnovax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Hester Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Onderstepoort Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Instituto Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Calier & Biologicos Laverlam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Biovet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Brucellosis Vaccines
Figure 107. Manufacturing Process Analysis of Brucellosis Vaccines
Figure 108. Brucellosis Vaccines Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Brucellosis Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 113. North America Brucellosis Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Brucellosis Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Brucellosis Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Brucellosis Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Brucellosis Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Brucellosis Vaccines Sales (M Doses) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Brucellosis Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Brucellosis Vaccines Sales (M Doses) and Growth Rate Forecast

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs